000180638 001__ 180638
000180638 005__ 20240229145626.0
000180638 0247_ $$2doi$$a10.1016/j.lanepe.2022.100451
000180638 0247_ $$2pmid$$apmid:35799615
000180638 0247_ $$2pmc$$apmc:PMC9253902
000180638 0247_ $$2altmetric$$aaltmetric:130855886
000180638 037__ $$aDKFZ-2022-01443
000180638 041__ $$aEnglish
000180638 082__ $$a610
000180638 1001_ $$0P:(DE-HGF)0$$aHeisser, Thomas$$b0$$eFirst author
000180638 245__ $$aImpact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study.
000180638 260__ $$a[Amsterdam]$$bElsevier$$c2022
000180638 3367_ $$2DRIVER$$aarticle
000180638 3367_ $$2DataCite$$aOutput Types/Journal article
000180638 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1657539214_14138
000180638 3367_ $$2BibTeX$$aARTICLE
000180638 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000180638 3367_ $$00$$2EndNote$$aJournal Article
000180638 500__ $$a#EA:C070#LA:C070#LA:C120#
000180638 520__ $$aDemographic aging is expected to increase the number of colorectal cancer (CRC) cases in many countries. Screening for CRC can substantially reduce the disease burden but its use has remained rather limited in Germany. We aimed to quantify the expected impact of demographic aging on the future CRC burden and the potential to reduce that burden by increased use of screening colonoscopy offers in Germany.We obtained sex- and age-specific data on colonoscopy use from AOK, the biggest health insurance provider in Germany, and combined these with the projected demographic development and current CRC incidence rates. We estimated the number of new CRC cases until 2060, assuming screening colonoscopy use to be constant or to increase to between 1·5 and 3 times the current levels.Ten-year screening colonoscopy utilization rates were low (<20% in both sexes in all age groups). Assuming no change in screening colonoscopy use, the overall annual caseload was predicted to increase from approximately 62,000 cases in 2020 to more than 70,000 cases by the year 2040 and more than 75,000 cases by 2050. To avoid increasing case numbers, an increase of screening colonoscopy use to more than 3 times current levels would be needed.At current levels of screening use, the strong effects of the demographic aging imply that the CRC caseload will significantly increase in the decades to come. CRC screening efforts will need to be substantially increased to even maintain the current level of incident cases.German Federal Ministry of Education and Research (grant 01GL1712).
000180638 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000180638 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000180638 650_7 $$2Other$$aAdherence
000180638 650_7 $$2Other$$aColonoscopy
000180638 650_7 $$2Other$$aColorectal cancer
000180638 650_7 $$2Other$$aForecasting
000180638 650_7 $$2Other$$aScreening
000180638 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b1$$udkfz
000180638 7001_ $$aTillmanns, Hanna$$b2
000180638 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$eLast author$$udkfz
000180638 773__ $$0PERI:(DE-600)3055963-7$$a10.1016/j.lanepe.2022.100451$$gVol. 20, p. 100451 -$$p100451$$tThe lancet / Regional health. Europe$$v20$$x2666-7762$$y2022
000180638 909CO $$ooai:inrepo02.dkfz.de:180638$$pVDB
000180638 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000180638 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000180638 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000180638 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000180638 9141_ $$y2022
000180638 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-25
000180638 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-25
000180638 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-12-02T13:40:13Z
000180638 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-12-02T13:40:13Z
000180638 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-12-02T13:40:13Z
000180638 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-25
000180638 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2022-11-25
000180638 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-25
000180638 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-25
000180638 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000180638 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000180638 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000180638 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000180638 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000180638 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000180638 980__ $$ajournal
000180638 980__ $$aVDB
000180638 980__ $$aI:(DE-He78)C070-20160331
000180638 980__ $$aI:(DE-He78)C120-20160331
000180638 980__ $$aI:(DE-He78)HD01-20160331
000180638 980__ $$aUNRESTRICTED